Fluid treatment system for a patient
The fluid treatment system addresses inefficiencies in toxin removal by employing dual dialyzers and pH/bicarbonate adjustment, enhancing toxin extraction and pH regulation for improved dialysis efficacy.
WO2026119890A1 Publication Date: 2026-06-11ADVITOS GMBH
5 Cites 0 Cited by
Patent Information
- Application Number
- PCT/EP2025/085117
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-03
- Filing Date
- 2025-12-02
- Publication Date
- 2026-06-11
AI Technical Summary
Technical Problem
Existing dialysis systems face inefficiencies in toxin removal, particularly for protein-bound toxins like albumin, and lack effective pH regulation and buffering capacity, leading to suboptimal treatment outcomes.
Method used
A fluid treatment system with independent pH control and adjustment modules, utilizing dual dialyzers and recirculation circuits with detoxification units, allows for continuous dialysis and purification of protein-containing dialysate, adjusting pH and bicarbonate levels to enhance toxin extraction and acid-base balance.
Benefits of technology
The system effectively removes water-soluble and protein-bound toxins, including albumin, while optimizing pH and bicarbonate levels, improving dialysis efficiency and reducing water consumption.
✦ Generated by Eureka AI based on patent content.
Abstract
The present disclosure relates to a fluid treatment patient system for a patient, comprising at least one protein dialysis circuit to remove water soluble and protein bound toxins, especially wherein the protein is preferably albumin, wherein the dialysis circuit comprises at least one or two dialyzers, wherein the circuit is configured to perform the dialysis at least such that a continuous recirculation and purification of the protein containing dialysate, preferably albumin containing dialysate, is performed, especially wherein these treatments are preferably performed with two dialyzers or one single dialyzer, and wherein the membrane areas is sufficient for toxin elimination.
Need to check novelty before this filing date? Find Prior Art